FIELD: organic chemistry, biochemistry, enzymes. SUBSTANCE: invention relates to novel compounds of the general formula (I): where R1 is taken among a group consisting of hydrogen atom, unsubstituted or optionally substituted aralkyl, substituted or optionally substituted aralkyloxycarbonyl, unsubstituted or optionally substituted alkyloxy-carbonyl, unsubstituted or optionally substituted alkyl and hydroxy-protective group; R2 is taken among a group consisting of hydrogen atom, unsubstituted or optionally substituted aralkyloxycarbonyl, unsubstituted or optionally substituted alkyloxycarbonyl, amino-protecting group; R3 is taken among a group consisting of hydrogen atom, unsubstituted or optionally substituted alkyl and unsubstituted or optionally substituted aralkyl; R4 is taken among a group consisting of unsubstituted or optionally substituted alkyl and unsubstituted or optionally substituted aralkyl; R5 and R6 can be similar or different being each is taken independently among a group consisting of hydrogen atom, unsubstituted or optionally substituted alkyl, unsubstituted or optionally substituted cycloalkyl, unsubstituted or optionally substituted heterocyclic group and amino-protecting group; or R5 and R6 taken in common with nitrogen atom to which they are bound form unsubstituted or optionally substituted heterocyclic group; R7 is taken among a group consisting of hydrogen atom, hydroxy-group, unsubstituted or optionally substituted alkyl and unsubstituted or optionally substituted aralkyl; R8 is taken among a group consisting of hydrogen atom, hydroxy-group, unsubstituted or optionally substituted alkyl and unsubstituted or optionally substituted aralkyl; R9 is taken among a group consisting of hydrogen atom, hydroxy-group, amino-group and group of the formula: -X-Y where X is taken among a group consisting of unsubstituted or optionally substituted (C1-C6)-alkylene and unsubstituted or optionally substituted phenylene; Y means a group of the formula: -A-B or B where A is taken among a group consisting of unsubstituted or optionally substituted (C1-C6)-alkylene, imino-group and unsubstituted or optionally substituted (C1-C6)- alkyleneimino-group; B is taken among a group consisting of hydrogen atom, amino-group, amidino-group, acylamidoyl-group, unprotected or optionally protected bis-(phosphono)-methyl under condition that R7, R8 and R do not mean simultaneously methyl, or its pharmaceutically acceptable salts. Invention relates also to two different methods of synthesis of compounds of the formula (I), intermediate compounds of formulas (III) , (IV) and (VI) used for synthesis of compounds of the formula (I), method of synthesis of compound of the formula (I), to pharmaceutical or veterinary composition and inhibitor of metalloproteinase. EFFECT: improved methods of synthesis, valuable biochemical properties of compounds. 15 cl, 4 tbl, 107 ex
Title | Year | Author | Number |
---|---|---|---|
NAPHTHALENE DERIVATIVES AND METHOD OF PREPARATION THEREOF | 1996 |
|
RU2129120C1 |
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
SULFATED AMINO ACID DERIVATIVES AND METALLOPROTEINASE INHIBITORS COMPRISING THEREOF | 1997 |
|
RU2198656C2 |
COMBINATED INHIBITORS OF FBP-ASE AND ANTIDIABETIC AGENTS FOR DIABETES TREATMENT | 2001 |
|
RU2328308C2 |
HETEROCYCLIC COMPOUND, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2221792C2 |
BISAMIDATE PHOSPHONATE COMPOUNDS AS INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE | 2000 |
|
RU2273642C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
DERIVATIVES OF K-252A | 1997 |
|
RU2205184C2 |
DERIVATIVES OF HYDROXYIMINOALKANOIC ACID, PHARMACEUTICAL COMPOSITION AND AGENT FOR REGULATION OF RETINOID RECEPTORS | 1999 |
|
RU2213738C2 |
TAXANES, PHARMACEUTICAL COMPOSITIONS, INHIBITION METHOD | 2001 |
|
RU2265019C2 |
Authors
Dates
2003-03-10—Published
1998-12-11—Filed